two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide)
April 2013
You'll hear about two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide).
But they're NOT for the vast majority of lipid patients.
They're for patients with homozygous familial hypercholesterolemia...which occurs in about one in 1,000,000 people.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote